Abstract
Most of us discover for ourselves that joints have a sensory innervation: twisting an ankle or knee is acutely painful and may lead to longer-lasting pain and inflammation which eventually disappears as the joint heals. We distinguish between sharp transient pain, which signals that damage or potential damage is occurring and initiates a protective reflex, and the less intense but persistent dull inflammatory pain that causes us to immobilise and guard the affected joint while it heals. We thus know from personal experience that different types of “normal” pain exist, and that inflammation is part of the normal healing process. But what provokes the chronic pain of inflammatory joint disorders such as rheumatoid arthritis (RA) where the alarm or protective aspect of pain becomes intolerable and damaging to the suffer-er?
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lewis T (1935) Experiments relating to cutaneous hyperalgesia and its spread through somatic nerves. Clin Sci 2: 373–423
Jancsó N, Jancsó-Gábor A, Szolcsányi J (1967) Direct evidence for neurogenic inflam-mation and its prevention by denervation and pretreatment with capsaicin. Br J Pharmacol 31: 32–41
Levine JD, Collier DH, Basbaum, AI, Moskowitz, MA, Helms CA (1985) Hypothesis:the nervous system may contribute to the pathophysiology of rheumatoid arthritis. J Rheumatol 12: 406–411
Levine JD, Goetzl EJ, Basbaum AI (1987) Contribution of the nervous system to the pathophysiology of rheumatoid arthritis and other polyarthritides. Rheum Dis Clin N Amer 13: 369–383
Fitzgerald M (1989) Arthritis and the nervous system. Trends Neurosci 12: 86–87
Kidd BL, Mapp PI, Blake DR, Gibson SJ, Polak JM (1990) Neurogenic influences in arthritis. Ann Rheum Dis 49: 649–652
Maggi CA (1991) The pharmacology of the efferent function of sensory nerves. J Auton Pharmacol 11: 173–208
Levine JD, Fields HL, Basbaum AI (1993) Peptides and the primary afferent nociceptor.J Neurosci 13: 2273–2286
Schaible H-G, Grubb BD (1993) Afferent and spinal mechanisms of joint pain. Pain 55:5–54
Kidd BL, Morris VH, Urban L (1996) Pathophysiology of joint pain. Ann Rheum Dis 55: 276–283
Ferrell WR (1992) Articular proprioception and nociception. Rheumatol Rev 1: 161–167
Kellgren JH Samuel EP (1950) The sensitivity and innervation of the articular capsule. J Bone & Joint Surgery 32B: 84–92
Hildebrand C, Öqvist G, Brax L, Tuisku F (1991) Anatomy of the rat knee joint and fibre composition of a major articular nerve. Anat Rec 229: 545–555
Mapp PI, Kidd BL, Merry P, Abdel-Rahim H, Blake DR, Gibson SJ, Polak JM (1989) Total innervation of the knee joint, an immunohistochemical study. Br J Rheumatol 28: Suppl 2: 39
Mapp PI, Kidd BL, Gibson SJ, Terry JM, Revell PA, Ibrahim NBM, Blake DR, Polak JM (1990) Substance P-, calcitonin gene-related peptide-and C-flanking peptide of neuropeptide Y like-immunoreactive nerve fibres are present in the normal synovium but depleted in patients with rheumatoid arthritis. Neurosci 37: 143–153
Iwasaki A, Inoue K, Hukuda S (1995) Distribution of neuropeptide-containing nerve fibres in the synovium and adjacent bone of the rat knee joint. Clin Exp Rheumatol 13: 173–178
Heppelmann B, Messlinger K, Neiss, WF, Schmidt RF (1990) Ultrastructural three-dimensional reconstruction of group III and group IV sensory endings (“free nerve endings”) in the knee joint capsule of the cat: evidence for multiple receptive sites. J Comp Neurol 292: 103–116
Cook SP, Vulchanova L, Hargreaves MN, Elde R, McCleskey EW (1997) Distinct ATP receptors on pain-sensing and stretch-sensing neurons. Nature 387: 505–508
Birrell GJ, McQueen DS (1993) The effects of capsaicin, bradykinin, PGE2 and cicaprost on the discharge of atricular sensory receptors in vitro. Brain Res 611: 103–107
Torebjörk E Hallin RG (1973) Perceptual changes accompanying controlled preferential blocking of A and C fibre responses in human intact skin nerves. Exp Brain Res 16: 321
Caterina MJ, Schumacher MA, Toninaga M, Rosen TA, Levine JD, Julius D (1997) The capsaicin receptor: a heat activated ion channel in the pain pathway. Nature 389: 816–824
Bevan SJ, Docherty RJ (1993) Cellular mechanisms of the action of capsaicin. In: JN Wood (ed): Capsaicin in the study of pain. Academic Press, London, 27–44
Schaible H-G, Schmidt RF (1985). Effects of an experimental arthritis on the sensory properties of fine articular afferent units. J Neurophysiol 54: 1109–1122
Grubb BD, Birrell GJ, McQueen DS, Iggo A (1991) The role of PGE2 in the sensitization of mechanonociceptors in normal and inflamed ankle joints of the rat. Exp Brain Res 84: 383–392
Iggo A (1996) Sensory consequences of inflammation. In: Bostock H, Kirkwood PA, Pullen AH (eds): The neurobiology of disease. Cambridge University Press, Cambridge, 162–168
Guilbaud G (1991) Central neurophysiological processing of joint pain on the basis of studies performed in normal animals and in models of experimental arthritis. Can J Physiol Pharmacol 69: 637–646
Woolf CJ, Doubell TP (1994) The pathophysiology of chronic pain - increased sensitivity to low threshold Aß fibre inputs. Curr Opin Neurobiol 4: 524–534
Ren K (1996) Primary afferents and inflammatory hyperexcitability. Pain 67: 1–2
Neumann S, Doubell TP, Leslie T, Woolf CJ (1996) Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature 384: 360–364
Thompson SW, Dray A, Urban L (1994). Injury-induced plasticity of spinal reflex activity: NK1 neurokinin receptor activation and enhanced A- and C- fiber mediated responses in the rat spinal cord in vitro. J Neurosci 14, 3672–3687
Abbadie C, Trafton J, Liu H, Mantyh PW, Basbaum AI (1997) Inflammation increases the distribution of dorsal horn neurons that internalize the neurokinin-1 receptor in response to noxious and non-noxious stimulation. J Neurosci 17: 8049–8060
Munro FE, Fleetwood-Walker SM, Parker RM, Mitchell R (1993) The effects of neurokinin receptor antagonists on mustard-oil evoked activation of rat dorsal horn neurons. Neuropeptides 25: 299–305
Urban L, Nagi, I (1997) Is there a neuropeptide carousel? Trends Pharmacol Sci 18: 223–224
Rang HO, Dale MM, Ritter JM (eds) (1995) Local hormones, inflammation and allergy. In: Pharmacology, 3rd edition. Churchill Livingstone, Edinburgh, 243–280
Panayi GS (1992) The immunopathogenesis of rheumatoid arthritis. Rheumatol Rev 1: 63–74
Hopkins SJ, Rothwell, NJ (1995) Cytokines and the nervous system I: expression and recognition. Trends Neurosci 18: 83–88
Hopkins SJ, Rothwell NJ (1995) Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci 18: 130–136
Aloe L, Tuveri MA (1997) Nerve growth factor and autoimmune rheumatic diseases. Clin Exp Rheumatol 15: 433–438
Haslett C (1992) Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin Sci 83: 639–648
Áranson JA, Malone DG (1995) Role of mast cells in arthritis. Chem Immunol 62: 204–238
Ferrell WR Najafipour H (1992) Changes in synovial PO2 and blood flow in the rabbit knee joint due to stimulation of the posterior articular nerve. J Physiol 449: 607–617
Scott DT, Lam FY, Ferrell WR (1994) Acute joint inflammation — mechanisms and mediators. Gen Pharmacol 25: 1285–1296
Dean G, Hoyland JA, Denton J, Donn RP, Freemont AJ (1993) Mast cells in synovium and synovial fluid in osteoarthritis. Br J Rheumatol 32: 671–675
Bridges AJ, Malone DG, Jicinsky J, Chen M, Ory P, Engber W, Graziano FM (1991) Human synovial mast cell involvement in rheumatoid arthritis and osteoarthritis. Relationship to disease type, clinical activity, and anti-rheumatic therapy. Arthritis Rheum 34: 1116–1124
Meininger CJ, Zetter BR (1992) Mast cells and angiogenesis. Semin Cancer Biol 3: 73–79
Jansco N, Jancso-Gabor A, Szolcsanyi J (1967) Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol 31: 138–151
Barnes PJ, Belvisi MG, Rogers DF (1990) Modulation of neurogenic inflammation: novel approaches to inflammatory disease. Trends Pharmacol Sci 11: 185–189
Pozo MA, Balazs EA, Belmonte C (1997) Reduction in sensory responses to passive movements of inflamed knee joints by hylan, a hyaluonan derivative. Exp Brain Res 116:3–9
Iversen LL (1985) The possible role of neuropeptides in the pathophysiology of rheumatoid arthritis. J Rheumatol 12: 399–400
Basbaum AI, Levine JD (1991) The contribution of the nervous system to inflammation and inflammatory disease. Can J Physiol Pharmacol 69: 647–651
Holzer P (1988) Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins and other neuropeptides. Neurosci 24: 739–768
Nakamura-Craig M, Smith TW (1989) Substance P and peripheral inflammatory hyperalgesia. Pain 38:91–98
Garrett NE, Mapp PI, Cruwys SC, Kidd BL, Brake DR (1992) Role of substance P in inflammatory arthritis. Ann Rheum Dis 51 1014–1018
Kajekar R, Moore PK, Brain SD (1995) Essential role for nitric oxide in neurogenic inflammation in rat cutaneous microcirculation. Evidence for an endothelium-independent mechanism. Circ Res 76: 441–447
Kajekar R, Gupta P, Shepperson NB, Brain SD (1995) Effect of a 5-HT1 receptor agonist, CP-122,288 on oedema formation induced by stimulation of the rat saphenous nerve. Br J Pharmacol 115, 1–2
Cameron AA, Leah JD, Snow PJ (1988) The co-existence of neuropeptides in feline sensory neurons. Neurosci 27: 969–979
Neveu PJ, LeMoal M, (1990) Physiological basis for neuroimmunomodulation. Fund Clin Pharmacol 4: 281–305
Brain SD, Williams TJ (1988) Substance P regulates the vasodilator activity of calcitonin gene-related peptide. Nature 335: 73–75
Telser S, Marksteiner J, Hinterhuber H, Saria A (1995) Distribution of secretoneurinlike immunoreactivity in comparison with that of substance P in the spinal cord. Neurosci Lett 191: 83–86
Courtright LJ, Kuzell WC (1965) Sparing effect of neurological deficit and trauma on the course of adjuvant arthritis in the rat. Ann Rheum Dis 24: 360–368
Colpaert FC, Donnerer J, Lembeck F (1983) Effects of capsaicin on inflammation and on the substance P content of nervous tissue in rats with adjuvant arthritis. Life Sci 32: 1827–1834
Levine JD, Dardick SJ, Roizen MF, Helms C, Basbaum AI (1986) The contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J Neurosci 6: 3923–3929
Holzer P (1991) Capsaicin: cellular targets, mechanism of action and selectivity for thin sensory neurones. Pharmacol Rev 43: 143–201
Cruwys SC, Garrett NE, Kidd BL (1995) Sensory denervation with capsaicin attenuates inflammation and nociception in arthritic rats. Neurosci Lett 193: 205–207
Cervero F, Plenderleith MB (1987) Adjuvant arthritis in adult rats treated at birth with capsaicin. Acta Physiol Hungarica 69: 497–500
Szolcsányi J (1990) Capsaicin-sensitive chemoceptive B-afferents: a neural system with a dual sensory-efferent function. Behan Brain Sci 13: 316
Levine JD, Clark R, Devor M, Helms C, Moskowitz MA, Basbaum AI (1984) Intraneuronal substance P contributes to the severity of experimental arthritis. Science 226: 547–549
Ferrell WR, Lockhart JC, Karimian SM (1997) Tachykinin regulation of basal synovial blood flow. Br J Pharmacol 121:29–34
McDougall JJ, Karimian SM, Ferrell WR (1994) Alteration of substance P-mediated vasodilatation and sympathetic vasoconstriction in the rat knee joint by adjuvant-induced inflammation. Neurosci Lett 174: 127–129
Mapp PI, Walsh DA, Garrett N, Cruwys SC, Kidd BL, Polak JM, Blake DR (1993) Experimental induction of inflammation induces nerve depletion in the synovium. Neuropeptides 24: 202–203
Larsson J, Ekbom A, Henrikson K, Lundeburg T, Theodorsson E (1991) Concentration of substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis. Scand J Rheumatol 20: 326–335.
Matucci-Cerinic M, Lombardi A, Leoncini G, Piganone A, Sacerdoti L, Spillantini MG, Partsch, G (1993) Neutral endopeptidase (3.4.24.11) in plasma and synovial fluid of patients with rheumatoid arthritis. A marker of disease activity and a regulator of pain and inflammation. Rheumatol International 13: 1–4
Donaldson LF, Harmar AJ, McQueen DS, Seckl JR (1992) The increased expression of preprotachykinin, calcitonin gene-related peptide, but not vasoactive intestinal polypeptide messenger RNA in dorsal root ganglia during the development of adjuvant monoarthritis in the rat. Mol Brain Res 16: 143–149
Ferrell WR, Russell JW (1986) Extravasation in the knee induced by antidromic stimulation of articular C fibre afferents of the anaesthetised cat. J Physiol 379: 407–416
Smith GD, Harmar AJH, McQueen DS, Seckl JR (1992) Increase in substance P and CGRP, but not somatostatin content of innervating dorsal root ganglia in adjuvant monoarthritis in the rat. Neurosci Lett 137: 257–260
Schaible H-G, Jarrott B, Hope PJ, Duggan AW (1990) Release of immunoreactive substance P in the spinal cord during development of acute arthritis in the knee joint of the cat: a study with antibody microprobes. Brain Res 529: 214–223
Garrett NE, Kidd BL, Cruwys SC, Tomlinson DR (1995) Changes in preprotachykinin mRNA expression and substance P levels in dorsal root ganglia of monoarthritic rats: comparison with changes in synovial substance P levels. Brain Res 675: 303–207
Mapp PI, Walsh DA, Garrett NE, Kidd BL, Cruwys SC, Polak JM, Blake DR (1994) Effect of three animal models of inflammation on nerve fibres in the synovium. Ann Rheum Dis 53: 240–246
Donaldson LF, Seckl JR, McQueen DS (1993) A discrete adjuvant-induced monoarthritis in the rat — effects of adjuvant dose. J Neurosci Methods 49: 5–10
Donaldson LF, McQueen DS, Seckl JR (1994) Local anesthesia prevents acute inflammatory changes in neuropeptide messenger RNA expression in rat dorsal root ganglia. Neurosci Lett 175: 111–113
Donaldson LF, McQueen DS, Seckl JR (1995) Neuropeptide gene-expression and capsaicin-sensitive primary afferents — maintenance and spread of arthritis in the rat. J Physiol 486: 473–482
Bulling DGS, McQueen DS, Seckl JR (1996) The early induction of neuropeptide messenger RNA in dorsal root ganglia during development of adjuvant arthritis. J Physiol 495: 24–25
Calza L, Pozza M, Zanni M, Manzini U, Manzini E, Hökfelt T (1997) Peptide plasticity in primary sensory neurons and spinal cord during adjuvant-induced arthritis in the rat: an immunocytochemical and in situ hybridization study. Neurosci 82: 574–589
Kidd BL, Mapp PI, Gibson SJ, Polak JM, O’Higgins F, Buckland-Wright JC, Blake DR (1990) A neurogenic mechanism for symmetrical arthritis. Lancet ii: 1128–1130
Kidd BL, Cruwys SC, Garrett NE, Mapp PI, Jolliffe VA, Blake DR (1995) Neurogenic influences on contralateral responses during experimental rat monoarthritis. Brain Res 688: 72–76
Mapp PI, Terengi G, Walsh DA, Chen ST, Cruwys SC, Garrett NE, Kidd BL, Polak JM, Blake DR (1993) Monoarthritis in the rat knee induces bilateral and time-dependent changes in substance P and calcitonin gene-related peptide immunoreactivity in the spinal cord. Neurosci 57: 1091–1096
Levine JD, Coderre TJ, Helms C, Basbaum AI (1988) ß2 adrenergic mechanisms in experimental arthritis. Proc Nat Acad Sci USA 85: 4553–4556
Nakamura M, Ferreira SH (1987) A peripheral sympathetic component in inflammatory hyperalgesia. Eur J Pharmacol 135: 143–153
Koltzenburg M, McMahon SB (1991) The enigmatic role of the sympathetic nervous system in chronic pain. Trends Pharmacol Sci 12: 399–402
Wall PD Gutnick M (1974) Properties of afferent nerve impulses originating from a neu-roma. Nature 248 740–743
Wakisaka S, Kajander KC, Bennett GJ (1992) Effects of peripheral nerve injury and tissue inflammation on the levels of neuropeptide Y-like immunoreactivity in rat primary afferent neurons. Brain Res 598: 349–352
Devor M (1983) Nerve pathophysiology and mechanisms of pain in causalgia. J Aut Nery Syst 7: 371–384
Sluka KA, Lawand NB, Westlund KN (1994) Joint inflammation is reduced by dorsal rhizotomy and not by sympathectomy or spinal cord transection. Ann Rheum Dis 53: 309–314
Di Virgilio F (1995) The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol Today 16: 524–528
Schott GD (1994) Visceral afferents: their contribution to “sympathetic dependent” pain. Brain 117: 397–413
Dray A, Urban L, Dickenson A (1994) Pharmacology of chronic pain. Trends Pharmacol Sci 15: 190–197
Perkins M, Dray A (1996) Novel pharmacological strategies for analgesia. Ann Rheum Dis 55: 715–722
Vane JR, Botting RM (1996) Mechanism of action of anti-inflammatory drugs. Scand J Rheumatol (Suppl) 102: 9–21
Spangler RS (1996) Cyclooxygenase 1 and 2 in rheumatic disease: implications for non-steroidal anti-inflammatory drug therapy. Semin Arthritis Rheum 26: 435–446
Brune K, Beck WS, Geisslinger G, Mendel-Sogolowek S, Peskar BM, Peskar BA (1991) Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition. Experientia 47: 257–261
Birrell GJ, McQueen DS, Iggo A, Coleman RA, Grubb BD (1991) PGI2-induced activation and sensitization of articular mechanonociceptors. Neurosci Lett 124: 5–8
McQueen DS, Iggo A, Birrell GJ, Grubb BD (1991) Effects of paracetamol and aspirin on neural activity of joint mechanonociceptors in adjuvant arthritis. Br J Pharmacol 104: 178–182
Barnes PJ, Adcock I (1993) Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 14: 436–441
Mantyh PW, Rogers SD, Honore P, Allen BJ, Ghilardi JR, Li J, Daughters, RS, Lappi DA, Wilet RG, Simone DA (1997) Inhibition of hyperalgesia by ablation of lamina 1 spinal neurons expressing the substance P receptor. Science 278: 275–279
Ferreira SH, Romitelli M, DiNucci G (1989) Endothelin-1 participation in overt inflammatory pain. J Cardiovasc Pharmacol 13: S200–202
Gutierrez S, Palacios I, Egido J, Gomez-Garre D, Hernandez P, Gonzalez E, Herrero-Beaumont G (1996) Endothelin-1 induces loss of proteoglycans and enhances fibronectin and collagen production in cultures rabbit synovial cells. Eur J Pharmacol 302: 191–197
Helyes Z, Nemeth J, Pinter E, Szolcsanyi J (1997) Inhibition by nociceptin of neurogenic inflammation and the release of SP and CGRP from sensory nerve terminals. Br J Pharmacol 121: 613–615
Cambridge H, Brain SD (1995) Mechanism of bradykinin-induced plasma extravasation in the rat knee joint. Br J Pharmacol 115: 641–647
Cruwys SC, Garrett NE, Perkins MN, Blake DR, Kidd BL (1994) The role of bradykinin B1 receptors in the maintenance of intra-articular plasma extravasation in chronic antigen-induced arthritis. Br J Pharmacol 113, 940–944
Cauli A, Yanni G, Panayi GS (1997) Interleukin-1, interleukin-1 receptor antagonist and macrophage populations in rheumatoid arthritis synovial membrane. Br J Rheumatol 36: 935–940
Arend WP, Dayer J-M (1995) Inhibition of the production and effects of interleukin-1 and tumor necrosis factor a in rheumatoid arthritis. Arthritis & Rheumatism 38: 151–160
Holton P (1059) The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves. J Physiol 145: 494–504
Burnstock G, Wood JN (1996) Purinergic receptors: their role in nociception and primary afferent neurotransmission. Curr Opin Neurobiol 6: 526–532
Ferrari D, Chiozzi P, Falzoni S, Dal Susino M, Melchiorri L, Baricordi OR, Di Virgilio F (1997) Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol 159: 1451–1458
Gu JG, MacDermott AB (1997) Activation of ATP P2X receptors elicits glutamate release from sensory neuron synapses. Nature 389:749–753
Liu H, Mantyh PW, Basbaum AI (1997) NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature 381: 793–796
Suprenant A, Rassendren F, Kawashima E, North RA, Buell G (1996) The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272: 735–738
Bland-Ward P, Humphrey PPA (1997) Acute nociception mediated by hind paw P2X receptor activation in the rat. Br J Pharmacol 122: 365–371
Dowd E, McQueen DS, Chessell IP, Humphrey PPA (1998) P2X receptor-mediated excitation of nociceptive afferents in the normal and arthritic rat knee joint. Br J Pharmacol 125: 341–346
Sawynok J, Zarridast MR, Reid AR, Doak GJ (1997) Adenosine A3 receptor activation produces nociceptive behaviour and edema by release of histamine and 5-hydroxytryptamine. Eur J Pharmacol 333: 1–7
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Basel AG
About this chapter
Cite this chapter
McQueen, D.S. (1999). Inflammatory pain and the joint. In: Brain, S.D., Moore, P.K. (eds) Pain and Neurogenic Inflammation. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8753-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8753-3_8
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9758-7
Online ISBN: 978-3-0348-8753-3
eBook Packages: Springer Book Archive